摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[Li(TMEDA)2][1,4,2-P2SbC2(Bu(t))2] | 180906-65-4

中文名称
——
中文别名
——
英文名称
[Li(TMEDA)2][1,4,2-P2SbC2(Bu(t))2]
英文别名
——
[Li(TMEDA)2][1,4,2-P2SbC2(Bu(t))2]化学式
CAS
180906-65-4
化学式
C10H18P2Sb*C12H32LiN4
mdl
——
分子量
561.304
InChiKey
CAKPFFHCEABPQB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    [Li(TMEDA)2][1,4,2-P2SbC2(Bu(t))2] 在 FeCl3 作用下, 以 乙二醇二甲醚 为溶剂, 以65%的产率得到(3R,3aR,7R)-2,3a,5,7-tetra-tert-butyl-3aH,7H-3,4,7-(epistibanetriyl)[1,4,2]diphosphastibolo[3,2-d][1,3,5]diphosphastibinine
    参考文献:
    名称:
    金属介导的二磷灰烷基环阴离子[ 1,4,2 -P 2 SbC 2 Bu t 2 ] –的偶联:新型含锑笼型化合物的合成与表征
    摘要:
    两当量的二磷酸雌二醇环阴离子[ 1,4,2 -P 2 SbC 2 Bu t 2 ] –与FeCl 3反应,通过氧化生成含锑的笼型化合物P 4 Sb 2 C 4 Bu t 4。耦合机制。当用[W(CO)5(thf )](thf =四氢呋喃)处理时,该笼子发生分子内重排反应,生成复合物[{W(CO)5 } P 4 Sb 2 C 4 Bu t 4X射线晶体学表明它含有三元PPC'二膦'环。的治疗顺- [氯铂酸2(PET 3)2 ]与1当量的[1,4,2-P 2 SBC 2卜吨2 ] - ,得到的复合体,第一个例子的反式- [氯铂酸(PET 3)2(η 1 -P 2 SBC 2卜吨2)],含有仅η 1-配位的二磷酸雌二醇基环。该化合物的晶体结构显示杂环在配位后保持其芳香性。的治疗顺- [氯铂酸2(PET 3)2 ]与2个当量的[1,4,2-P 2 SBC 2卜吨2 ] -发起在金属环偶合反应,得到新笼型络合物的顺式-
    DOI:
    10.1039/a704809b
点击查看最新优质反应信息

文献信息

  • Novel triphospholyl and diphosphastibolyl lead(II) complexes
    作者:Julie J. Durkin、Matthew D. Francis、Peter B. Hitchcock、Cameron Jones、John F. Nixon
    DOI:10.1039/a905830c
    日期:——
    PbCl2 reacted with the triphospholyl ring anion [P3C2But2]– to afford the hexaphospha-plumbocene [Pb(η5-P3C2But2)2] 3 which has been characterised by multinuclear NMR spectroscopy. In contrast the reaction between PbCl2 and the diphosphastibolyl ring anion [P2SbC2But2]– led to the organo-antimony cage compound [P4Sb2C4But4] 4via an oxidative coupling route. Both the heteroleptic plumbocenes [Pb(η5-EP2C2But2)(η5-C5Me5)] (E = P 5, E = Sb 6) could be prepared by treatment of the corresponding hetero-ring anion with a mixture of PbCl2 and Li(C5Me5) (for 5) or the half sandwich complex [Pb(η5-C5Me5)Cl] (for 6). Both complexes were characterised by multinuclear NMR spectroscopy and single crystal X-ray diffraction studies. The novel, structurally characterised, hetero-bimetallic complex [Pb(η5-P3C2But2)(µ-Cl)2Li(tmen)2] 7 could be synthesised by carrying out the reaction of PbCl2 with [Li(dme)3][P3C2But2] in tmen rather than dme. This compound was found to be highly fluxional in solution even at low temperature.
    PbCl2与三磷杂茂环阴离子[P3C2But2]–反应,得到了六茂[Pb(η5-P3C2But2)2] 3,该化合物已通过多核NMR光谱进行了表征。相比之下,PbCl2与二膦茂环阴离子[P2SbC2But2]–反应,通过氧化偶联路线得到了有机笼合物[P4Sb2C4But4] 4。通过处理相应的杂环阴离子与PbCl2和Li(C5Me5)(对于5)或半夹心配合物[Pb(η5-C5Me5)Cl](对于6)的混合物,可以制备两种异配位茂[Pb(η5-EP2C2But2)(η5-C5Me5)](E = P 5,E = Sb 6)。这两种配合物均通过多核NMR光谱和单晶X射线衍射研究进行了表征。通过在tmen而非dme中进行PbCl2与[Li(dme)3][P3C2But2]的反应,可以合成新型、结构表征的杂双属配合物[Pb(η5-P3C2But2)(µ-Cl)2Li(tmen)2] 7。该化合物在溶液中甚至在低温下都表现出高度流动性。
  • Synthesis, crystal and molecular structure of a novel organoantimony cage compound, C4But4P4Sb2
    作者:Steven J. Black、Matthew D. Francis、Cameron Jones
    DOI:10.1039/a607672f
    日期:——
    The reaction of the hetero-ring anion [P 2 SbC 2 Bu t 2 ] - with FeCl 3 affords the organoantimony cage compound, C 4 Bu t 4 P 4 Sb 2 , via a proposed oxidative coupling reaction; the X-ray crystal structure of the cage displays weak intermolecular interactions.
    杂环阴离子的反应 [P 2 碳化 2 布 t 2 ] - 与氯化亚铁 3 提供有机笼状化合物, C 4 布 t 4 4 2 , 通过拟议的氧化偶联反应; X射线晶体 笼结构显示出弱的分子间相互作用。
  • Synthesis and Structural Characterization of a Novel Polyheterocyclopentadienyl Thallium(I) Complex
    作者:Matthew D. Francis、Cameron Jones、Glen B. Deacon、Ewan E. Delbridge、Peter C. Junk
    DOI:10.1021/om980239c
    日期:1998.8.1
    The reaction of [Li(TMEDA)2][1,4,2-P2SbC2But2] (1) with TlCl affords the compound [Tl(μ-η5:η5-1,4,2-P2SbC2But2)}∞] (2). Its X-ray crystal structure reveals a double-stranded zigzag polymeric chain structure with intermolecular thallium−phosphorus interactions.
    的反应[李(TMEDA)2 ] [1,4,2-P 2 SBC 2卜吨2 ](1)与TLCL,得到化合物[(μ-η 5:η 5 -1,4,2 -P 2 SBC 2 Bu t 2)} ∞ ](2)。它的X射线晶体结构揭示了具有分子间th-相互作用的双链之字形聚合物链结构。
  • Contrasting Binding Modes in Lanthanoid Pyrazolate and Pseudo-pyrazolates Prepared by Oxidation of Lanthanoid(II) Complexes and Lanthanoid Metals with Thallium(I) Reagents
    作者:Glen B. Deacon、Ewan E. Delbridge、Gary D. Fallon、Cameron Jones、David E. Hibbs、Michael B. Hursthouse、Brian W. Skelton、Allan H. White
    DOI:10.1021/om990932f
    日期:2000.5.1
    ide ligand. After metathesis routes to Ln(1,4,2-P2SbC2But2)n complexes failed, redox transmetalation between ytterbium metal and [Tl(1,4,2-P2EC2But2)] (E = Sb, P) containing a substantial impurity of [Li(tmeda)2][1,4,2-P2EC2But2] yielded the first lanthanoid diphosphastibacyclopentadienide complex in a mixture with [1,2,4-P3C2But2] species. An X-ray investigation of single crystals containing an isomerically
    Yb(C 5 Me 5)2用[Tl(Ph 2 PZ)]和[Tl(azin)](Ph 2 PZ = 3,5-二苯基吡唑酸酯,azin = 7-氮杂吲哚酸酯)氧化得到[Yb(C 5 Me 5)2(Ph 2 PZ)](1)和[Yb(C 5 Me 5)2(azin)](2)。的X射线晶体结构1和2揭示了单体的八坐标配合物η 2 -Ph 2 PZ或嗪配体。用[Tl(Ph 2 PZ)]处理属可得到[Nd(Ph2 PZ)3(DME)2 ](3具有三个η),它是一个九坐标单体2个-pyrazolate配体螯合剂和一个单齿配位体的DME。氧化(C 5我5)2以[(1,4,2--P 2 SBC 2卜吨2)] / [(1,2,4-P 3 c ^ 2卜吨2)](约4:1)的混合物[Sm(C 5 Me 5)2(1,2,4-P 3 C 2 Bu t 2)](4)和[Sm(C 5 Me 5)2(1,4,2 -P
  • The first diphosphastibolyl complexes: synthesis and characterisation of [Ru(η<sup>5</sup>-C<sub>5</sub>R<sub>5</sub>)(η<sup>5</sup>-C<sub>2</sub>Bu<sup>t</sup><sub>2</sub>P<sub>2</sub>Sb)]; R = H or Me
    作者:Matthew D. Francis、David E. Hibbs、Michael B. Hursthouse、Cameron Jones、K. M. Abdul Malik
    DOI:10.1039/cc9960001591
    日期:——
    Treatment of the novel ring anion [C(2)Bu(2)(t)P(2)Sb](-) 4 with [Ru(eta(5)-C(5)R(5))(MeCN)(3)]PF6, (R = H, Me), affords the compounds [Ru(eta(5)-C(5)R(5))(eta(5)-(C2BU2P2Sb)-P-t)] (R = H 6, Me 7), which represent the first examples of complexes derived from a diphosphastibolyl ring; the X-ray crystal structure of 7 is described.
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)